Tuesday, 12 May 2020

India's Jubilant Signs Licensing Deal For US Pharma Firm's COVID-19 Drug

India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc's experimental COVID-19 treatment remdesivir in 127 countries,...

from NDTV News - Special https://ift.tt/3bqUqQ1

No comments:

Post a Comment

White House "Alarmed" After Taylor Swift, Joe Biden Deepfakes Surface

Deepfakes generated by artificial intelligence have proliferated on social media this month, claiming a string of high-profile victims and e...